Information  X 
Enter a valid email address

Regenersis PLC (RGS)

  Print          Annual reports

Wednesday 16 April, 2014

Regenersis PLC

RESULTS OF GENERAL MEETING

RNS Number : 9140E
Regenersis PLC
15 April 2014
 



THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, NEW ZEALAND, RUSSIA OR THE REPUBLIC OF SOUTH AFRICA OR ANY JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION IS UNLAWFUL

 

REGENERSIS PLC

("Regenersis" or the "Company")

 

RESULTS OF GENERAL MEETING

 

The Board of Regenersis announces that all resolutions put to shareholders at the Company's General Meeting earlier today were duly passed.

 

Application has been made for (i) the 28,986,000 new ordinary shares (the 'Placing Shares') to be issued to placees in connection with the Company's placing (the 'Placing'); and (ii) the 255,096 new ordinary shares (the 'Consideration Shares') to be issued to Kim Väisänen as part consideration for the acquisition (the 'Acquisition') of Blancco Oy Limited by Regenersis, to be admitted to trading on AIM.  Dealing is expected to commence in respect of both the Placing Shares and the Consideration Shares at 08:00 on 17 April 2014.  Subject to Admission occurring tomorrow morning and payment of the initial consideration under the Acquisition being made all the conditions for completion of the Acquisition have now been met or waived.

 

The Placing Shares and the Consideration Shares will, when issued, rank in full for all dividends and other distributions declared, made or paid on the Company's ordinary shares by reference to record dates falling after their date of issue and otherwise rank pari passu in all respects with the Company's existing ordinary shares, save that they will not entitle the holders to receive the interim dividend of 1.32 pence per ordinary share payable in respect of the six months to 31 December 2013 declared on 17 March 2014.

 

In conformity with rule 5.6.1 of the Disclosure and Transparency rules, the Board of the Company notifies the market that following the admission of the Placing Shares and Consideration Shares its total issued share capital will comprise 79,022,599 ordinary shares of 2 pence each.  The Company does not hold any of its ordinary shares in treasury and hence the number of ordinary shares with voting rights will be 79,022,599.

 

The figure of 79,022,599 ordinary shares may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of Regenersis under the FCA's Disclosure and Transparency Regime.

 

The figure of 78,080,436 ordinary shares may also be used by shareholders in basic earnings per share calculations.  This figure excludes those shares which are held on behalf of various employees of the Company in the Company's employment benefit trust.

 

Enquiries:

 

Regenersis Plc 

Matthew Peacock, Executive Chairman

Jog Dhody, Chief Financial Officer

 

+44 (0) 20 3657 7000

Panmure Gordon (UK) Limited (Nomad and Joint Broker)

Dominic Morley / Nicola Marrin, Corporate Finance

Charles Leigh Pemberton, Corporate Broking

 

+44 (0) 20 7886 2500

Cenkos Securities (Joint Broker)

Stephen Keys, Corporate Finance

Alex Aylen, Sales

 

+44 (0) 20 7397 8900

Tavistock Communications

Catriona Valentine / Matt Ridsdale / Emma Blinkhorn

+44 (0) 20 7920 3150

This announcement has been issued by Regenersis and is the sole responsibility of Regenersis. This announcement is for information purposes only and does not constitute an offer to sell or an invitation to subscribe for or a solicitation of an offer to buy or subscribe for any securities in any jurisdiction including in which such an offer or solicitation is unlawful and is not for distribution in or into, without limitation, the United Kingdom, United States, Canada, Australia, Japan, New Zealand, Russia or the Republic of South Africa (the 'Restricted Jurisdictions') or to US persons (within the meaning of Regulation S of the United States Securities Act 1933 (as amended) (the 'Securities Act')).

 

The Placing Shares and Consideration Shares have not been and will not be registered under the Securities Act or under the applicable securities laws of any state in the United States or any other Restricted Jurisdiction and, unless an exemption under such act or laws is available may not be offered for sale or subscription or sold or subscribed directly or indirectly within the Restricted Jurisdictions or for the account or benefit of any national, resident or citizen of the Restricted Jurisdictions. No public offering of securities will be made in the United States. The distribution of this announcement in other jurisdictions may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

 

Panmure Gordon and Cenkos Securities, which are authorised and regulated by the Financial Conduct Authority, are acting exclusively for Regenersis and for no one else in connection with the Placing and will not be responsible to anyone other than Regenersis for providing the protections afforded to clients of Panmure Gordon and Cenkos Securities nor for providing advice in relation to the Placing or any other matters referred to in this announcement.

 

About Regenersis - www.regenersis.com

 

With its core business in repairing consumer electronics, Regenersis helps companies like HTC, Nokia, Samsung, Orange, John Lewis, LG, Toshiba and others deliver the best possible after market service to its customers.  Through the provision of technical call centres or managing returns and repairs, the company supports a wide range of products including mobile phones, laptops and tablets, set top boxes, televisions and other electronic equipment.  Regenersis also operates in the business-to-business environment where it offers high quality and secure repair and refurbishment solutions for chip and pin devices, ATMs and even MRI scanners.

 

Building upon its success in repair, the company is already proving its pioneering range of services known as Advanced Solutions, which include in-field testing, where Regenersis is partnering with cable operators across the world to diagnose set-top box faults in the home, reducing unnecessary returns.  The newly formed Renew business unit comprises Digital Care, which provides extended warranty and insurance services to end customers; Refurbishment, which provides legitimate, quality refurbished components and devices to the end customer; and Recommerce, which offers client led refurbishment, repair and onward disposition of devices.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMIAMFTMBBBBRI

a d v e r t i s e m e n t